AT&T (T)
(Delayed Data from NYSE)
$18.90 USD
-0.11 (-0.58%)
Updated Jul 29, 2024 04:02 PM ET
After-Market: $18.92 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.90 USD
-0.11 (-0.58%)
Updated Jul 29, 2024 04:02 PM ET
After-Market: $18.92 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Zacks News
Should iShares MSCI USA Value Factor ETF (VLUE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VLUE
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD
New Strong Sell Stocks for March 6th
by Zacks Equity Research
T, AMRC and AHCHY have been added to the Zacks Rank #5 (Strong Sell) List on March 6, 2023.
Zacks Investment Ideas feature highlights: Meta Platforms, AT&T, BITB, IWM and Viking Therapeutics
by Zacks Equity Research
Meta Platforms, AT&T, BITB, IWM and Viking Therapeutics are part of the Zacks Investment Ideas article.
The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic
by Zacks Equity Research
Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic are part of the Zacks top Analyst Blog.
Beyond the "Mag 7": 3 Risk-On Market Forces
by Andrew Rocco
The biggest bear argument over the past year has been the slim leadership in the market, namely concentrated in mega-cap tech stocks like the "Mag 7." However, dig deeper, and you will discover that the market is broadening quickly.
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
Is iShares MSCI USA Value Factor ETF (VLUE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VLUE
Assessing Telecomm ETFs Amid Q4 Earnings
by Yashwardhan Jain
Look into how telecomm ETFs reacted to Q4 earnings.
New Strong Sell Stocks for January 29th
by Zacks Equity Research
T, DSRLF and HAFC have been added to the Zacks Rank #5 (Strong Sell) List on January 29, 2023.
Should You Retain American Tower (AMT) in Your Portfolio Now?
by Zacks Equity Research
American Tower (AMT) is likely to benefit from the solid demand for wireless connectivity and its strategic expansions. However, customer concentration and a high interest rate environment are major woes.
Company News for Jan 25, 2024
by Zacks Equity Research
Companies in The News Are: FCX, GD, T, AEP
Apple and Cenovus Energy have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Apple and Cenovus Energy have been highlighted as Zacks Bull and Bear of the Day.
AT&T (T) Misses Q4 Earnings Estimates Despite Higher Revenues
by Zacks Equity Research
Despite strong subscriber growth and robust cash flow position, AT&T (T) fail to beat fourth-quarter 2023 earnings estimate.
Compared to Estimates, AT&T (T) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for AT&T (T) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Fiber Deployment Cost Landscape 2023 & Industry Implications
by Supriyo Bose
Industry participants like AT&T (T), Verizon (VZ) and T-Mobile (TMUS) are likely to use this information to refine their cost management strategies, optimize deployment methods and make informed decisions.
Can Improved Latin America Revenues Aid AT&T (T) Q4 Earnings?
by Zacks Equity Research
In the fourth quarter, the Latin America segment of AT&T (T) is likely to have recorded higher revenues on a year-over-year basis despite a challenging macroeconomic environment and inflationary pressure owing to wireless traction.
Will Soft Communications Revenues Dent AT&T (T) Q4 Earnings?
by Zacks Equity Research
In the fourth quarter, the Communications segment of AT&T (T) is likely to have recorded year-over-year lower revenues despite a healthy traction in the wireless business, owing to a challenging macroeconomic environment.
Unveiling AT&T (T) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of AT&T (T) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Will Marginal Top-Line Growth Buoy AT&T's (T) Q4 Earnings?
by Zacks Equity Research
AT&T (T) is expected to have witnessed a top-line improvement year over year in fourth-quarter 2023, driven by steady investments for 5G expansion and fiber broadband infrastructure development.
Is a Surprise Coming for AT&T (T) This Earnings Season?
by Zacks Equity Research
AT&T (T) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog Highlights Apple, UnitedHealth Group, Exxon Mobil, The Boeing and AT&T
by Zacks Equity Research
Apple, UnitedHealth Group, Exxon Mobil, The Boeing and AT&T are part of the Zacks top Analyst Blog.
Top Stock Reports for Apple, UnitedHealth & Exxon Mobil
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH) and Exxon Mobil Corporation (XOM).
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPHD